Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$129.90 USD
+3.24 (2.56%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $129.90 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-1.48 | 80.39% |
Earnings Summary
For their last quarter, Ascendis Pharma (ASND) reported earnings of -$2.05 per share, missing the Zacks Consensus Estimate of -$1.54 per share. This reflects a negative earnings surprise of 33.12%. Look out for ASND's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$1.48 per share, reflecting a year-over-year increase of 52.56%.
Earnings History
Price & Consensus
Zacks News for ASND
Ascendis Pharma (ASND) Moves 17.1% Higher: Will This Strength Last?
ASND: What are Zacks experts saying now?
Zacks Private Portfolio Services